Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

Teenage cannabis users twice as likely as non-users to develop psychosis, bipolar disorder
The new research doesn’t solve the mystery of which tends to come first—the mental illness or the drug use. Regardless, the large study serves to underscore the need for proactive and preventive measures.
Cardiologist says new legislation would delay flawed payment cuts, preserve access to care
The efficiency adjustment cuts introduced in the 2026 MPFS are based on assumptions many doctors believe to be false. The American Society of Nuclear Cardiology and other medical societies are pushing back.
Nurse suing hospital for failing to head off vicious attack by patient
A hospital and its security contractor are facing legal trouble over a brutal beating taken by a unit nurse at the hands of a mentally ill inpatient a year ago.
Heart failure company BioVentrix files for IPO
The company, known for its advanced heart failure technologies, hopes to be traded on the Nasdaq under the symbol BVXX.
GE HealthCare nabs 3 notable MRI FDA clearances
On Feb. 19, the company announced the clearance of two new MRI systems and one artificial intelligence-enabled workflow platform.

Teenage cannabis users twice as likely as non-users to develop psychosis, bipolar disorder

The new research doesn’t solve the mystery of which tends to come first—the mental illness or the drug use. Regardless, the large study serves to underscore the need for proactive and preventive measures.

Friederike Keating, MD, director, nuclear cardiology, at University of Vermont Health, and chair of American Society of nuclear Cardiology (ASNC) Health Policy Committee, explains the support behind House Bill 7520 that aims to halt the Medicare's 2.5% efficiency adjustment cut to physician payments that was included in the 2025 Medicare Physician Fee Schedule.

Cardiologist says new legislation would delay flawed payment cuts, preserve access to care

The efficiency adjustment cuts introduced in the 2026 MPFS are based on assumptions many doctors believe to be false. The American Society of Nuclear Cardiology and other medical societies are pushing back.

Nurse suing hospital for failing to head off vicious attack by patient

A hospital and its security contractor are facing legal trouble over a brutal beating taken by a unit nurse at the hands of a mentally ill inpatient a year ago.

Heart failure company BioVentrix files for IPO

The company, known for its advanced heart failure technologies, hopes to be traded on the Nasdaq under the symbol BVXX.

GE HealthCare earns 3 new MRI FDA clearances

GE HealthCare nabs 3 notable MRI FDA clearances

On Feb. 19, the company announced the clearance of two new MRI systems and one artificial intelligence-enabled workflow platform.

The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.

Medtronic’s RDN system receives new reimbursement approval

More than 40 million adults now have improved access to Medtronic's Symplicity Spyral renal denervation technology.

Moderna, FDA reach compromise to accelerate approval of mRNA flu vaccine

The dispute centered around the pharmaceutical company's request for the shot to be approved for those aged 65 and over, a demographic the FDA argued was not properly represented in a 40,000-person clinical study. The company has agreed to perform additional research after the shot goes to market, having appeased regulators with safety data.

Federal court strikes down FTC mergers and acquisitions reporting rule

A U.S. District Court in Texas ruled that the agency overstepped its regulatory authority in passing the 2024 Biden-era reporting requirement, which would require stakeholders to spend more than 100 hours filling out a long form to give the agency more oversight of transactions.